Advertisement

Anabolic Mediators of Cartilage Healing

  • Naoshi Fukui
  • Linda J. Sandell
Chapter
Part of the Topics in Bone Biology book series (TBB, volume 4)

Keywords

Articular Cartilage Articular Chondrocytes Normal Cartilage Osteoarthritis Cartilage Human Articular Cartilage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abreu JG, Ketpura NI, Reversade B, De Robertis EM (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nature Cell Biol 4:599–604.PubMedGoogle Scholar
  2. 2.
    Adam M, Deyl Z 1983 Altered expression of collagen phenotype in osteoarthrosis. Clin Chim Acta 133:25–32.PubMedCrossRefGoogle Scholar
  3. 3.
    Aigner T, Bertling W, Stoss H, Weseloh G, von der Mark K (1993) Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest 91:829–837.PubMedGoogle Scholar
  4. 4.
    Aigner T, Dietz U, Stob H, von der Mark K (1995) Differential expression of collagen types I, II, III, and X in human osteophytes. Lab Invest 73:236–243.PubMedGoogle Scholar
  5. 5.
    Aigner T, Gluckert K, von der Mark K (1997) Activation of fibrillar collagen synthesis and phenotypic modulation of chondrocytes in early human osteoarthritic cartilage lesions. Osteoarthritis Cartilage 5:183–189.PubMedCrossRefGoogle Scholar
  6. 6.
    Aigner T, Zhu Y, Chansky HH, Matsen FA, 3rd, Maloney WJ, Sandell LJ (1999) Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum 42:1443–1450.PubMedCrossRefGoogle Scholar
  7. 7.
    Aigner T, Zien A, Gehrsitz A, Gebhard P, McKenna L (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44:2777–2789.PubMedCrossRefGoogle Scholar
  8. 8.
    Andriamanalijaona R, Felisaz N, Kim S, King-Jones K, Lehmann M, Pujol J, Boumediene K (2003) Mediation of interleukin-1beta-induced transforming growth factor beta1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1. Arthritis Rheum 48:1569–1581.PubMedCrossRefGoogle Scholar
  9. 9.
    Aurich M, Mwale F, Reiner A, Mollenhauer J, Anders J, Fuhrmann R, Kuettner K, Poole A, Cole A (2006) Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface. Arthritis Rheum 54:244–252.PubMedCrossRefGoogle Scholar
  10. 10.
    Aurich M, Squires G, Reiner A, Mollenhauer J, Kuettner K, Poole A, Cole A (2005) Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints. Arthritis Rheum 52:112–119.PubMedCrossRefGoogle Scholar
  11. 11.
    Bayliss MT, Ali SY (1978) Studies on cathepsin β in human articular cartilage. Biochem J 171:149–154.PubMedGoogle Scholar
  12. 12.
    Bobacz K, Gruber R, Soleiman A, Erlacher L, Smolen J, Graninger W (2003) Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. Arthritis Rheum 48:2501–2508.PubMedCrossRefGoogle Scholar
  13. 13.
    Bock HC (2001) The small proteoglycans decorin and biglycan in human articular cartilage of late-stage osteoarthritis. Osteoarthritis Cartilage 9:654–663.PubMedCrossRefGoogle Scholar
  14. 14.
    Chadjichristos C, Ghayor C, Herrouin J-F, Ala-Kokko L, Suske G, Pujol J-P, Galera P (2002) Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. J Biol Chem 277: 43903–43917.PubMedCrossRefGoogle Scholar
  15. 15.
    Chubinskaya S, Merrihew C, Cs-Szabo G, Mollenhauer J, McCartney J, Rueger DC, Kuettner KE (2000) Human articular chondrocytes express osteogenic protein-1. J Histochem Cytochem 48:239–250.PubMedGoogle Scholar
  16. 16.
    Clements K, Price J, Chambers M, Visco D, Poole A, Mason R (2003) Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum 48:3452–3463.PubMedCrossRefGoogle Scholar
  17. 17.
    Collins D, McElligott T (1960) Sulphate (35SO_4) uptake by chondrocytes in relation to histological changes in osteoarthritic human articular cartilage. Ann Rheum Dis 19:318–330.PubMedGoogle Scholar
  18. 18.
    Cs-Szabo G, Melching LI, Roughley PJ, Glant TT (1997) Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum 40:1037–1045.PubMedCrossRefGoogle Scholar
  19. 19.
    Cs-Szabo G, Roughley PJ, Plaas AH, Glant TT (1995) Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum 38:660–668.PubMedCrossRefGoogle Scholar
  20. 20.
    Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis. K Bobacz, R Gruber, A Soleiman, WB Graninger, FP Luyten, and L Erlacher Osteoarthritis Cartilage, May 1, 2002: 10(5):394–401.Google Scholar
  21. 21.
    Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P, Pottie P (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48:3118–3129.PubMedCrossRefGoogle Scholar
  22. 22.
    Eviatar T, Kauffman H, Maroudas A (2003) Synthesis of insulin-like growth factor binding protein 3 in vitro in human articular cartilage cultures. Arthritis Rheum 48:410–417.PubMedCrossRefGoogle Scholar
  23. 23.
    Fernihough JK, Billingham ME, Cwyfan-Hughes S, Holly JM (1996) Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis Rheum 39:1556–1565.PubMedCrossRefGoogle Scholar
  24. 24.
    Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Sveinbjornsson B (2001) Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 287:190–197.PubMedCrossRefGoogle Scholar
  25. 25.
    Flechtenmacher J, Huch K, Thonar E, Mollenhauer J, Davies S, Schmid T, Puhl W, Sampath T, Aydelotte M, Kuettner K (1996) Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 39:1896–1904.PubMedCrossRefGoogle Scholar
  26. 26.
    Fukui N, Purple C, Sandell L (2001) Cell biology of osteoarthritis: the chondrocyte’s response to injury. Curr Rheumatol Rep 3:496–505.PubMedCrossRefGoogle Scholar
  27. 27.
    Fukui N, Sandell L, Ikeda Y, Ohnuki T, Tanaka K, Yamamoto S, Ishibashi H, Sawabe M, Suzuki R, Ochi T (2005) Disturbed matrix gene expression in osteoarthritic chondrocytes. Orthop Res Soc 51:1409 (abstract)Google Scholar
  28. 28.
    Fukui N, Sandell L, Ikeda Y, Tanaka K, Yamamoto S, Ishibashi H, Sawabe M, Suzuki R, Ochi T (2005) Chondrocytes undergo phenotypic changes at the surface of osteoarthritic cartilage. Orthop Res Soc 51:343 (abstract)Google Scholar
  29. 29.
    Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ (2003) Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 85A (suppl 3):59–66.Google Scholar
  30. 30.
    Galera P, Vivien D, Pronost S, Bonaventure J, Redini F, Loyau G, Pujol JP (1992) Transforming growth factor-beta 1 (TGF-beta 1) up-regulation of collagen type II in primary cultures of rabbit articular chondrocytes (RAC) involves increased mRNA levels without affecting mRNA stability and procollagen processing. J Cell Physiol 153:596–606.PubMedCrossRefGoogle Scholar
  31. 31.
    Garnero P, Ayral X, Rousseau J, Christgau S, Sandell L, Dougados M, Delmas P (2002) Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 46:2613–2624.PubMedCrossRefGoogle Scholar
  32. 32.
    Glant T, Mikecz K, Roughley P, Buzas E, Poole A (1986) Age-related changes in protein-related epitopes of human articular-cartilage proteoglycans. Biochem J 236:71–75.PubMedGoogle Scholar
  33. 33.
    Guerne P, Blanco F, Kaelin A, Desgeorges A, Lotz M (1995) Growth factor responsiveness of human articular chondrocytes in aging and development. Arthritis Rheum 38:960–968.PubMedCrossRefGoogle Scholar
  34. 34.
    Hambach L, Neureiter D, Zeiler G, Kirchner T, Aigner T (1998) Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage. Arthritis Rheum 41:986–996.PubMedCrossRefGoogle Scholar
  35. 35.
    Hermansson M, Sawaji Y, Bolton M, Alexander S, Wallace A, Begum S, Wait R, Saklatvala J (2004) Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin βA (activin A), a regulatory molecule for chondrocytes. J Biol Chem 279:43514–43521.PubMedCrossRefGoogle Scholar
  36. 36.
    Homandberg G (2001) Cartilage damage by matrix degradation products: fibronectin fragments. Clin Orthop Relat Res 391:S100–107.PubMedCrossRefGoogle Scholar
  37. 37.
    Jones KA, Kadonaga JT, Rosenfeld PJ, Kelly TJ, Tjian R (1987) A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48:79–89.PubMedCrossRefGoogle Scholar
  38. 38.
    Kempson G, Muir H, Pollard C, Tuke M (1973) The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta 297:456–472.PubMedGoogle Scholar
  39. 39.
    Lafeber FP, van Roy HL, van der Kraan PM, van den Berg WB, Bijlsma JW (1997) Transforming growth factor-beta predominantly stimulates phenotypically changed chondrocytes in osteoarthritic human cartilage. J Rheumatol 24:536–542.PubMedGoogle Scholar
  40. 40.
    Lafeber FP, Vander Kraan PM, Huber-Bruning O, Vanden Berg WB, Bijlsma JW (1993) Osteoarthritic human cartilage is more sensitive to transforming growth factor beta than is normal cartilage. B J Rheumatol 32:281–286.CrossRefGoogle Scholar
  41. 41.
    Lippiello L, Hall D, Mankin HJ (1977) Collagen synthesis in normal and osteoarthritic cartilage. J Clin Invest 59:593–600.PubMedGoogle Scholar
  42. 42.
    Loeser R, Shanker G, Carlson C, Gardin J, Shelton B, Sonntag W (2000) Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 43:2110–2120.PubMedCrossRefGoogle Scholar
  43. 43.
    Loeser R, Varnum B, Carlson C, Goldring M, Liu E, Sadiev S, Kute T, Wallin R (1997) Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor axle: potential role in autocrine signaling in cartilage. Arthritis Rheum 40:1455–1465.PubMedCrossRefGoogle Scholar
  44. 44.
    Lorenzo P, Bayliss M, Heinegard D (2004) Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis. Matrix Biol 23:381–391.PubMedCrossRefGoogle Scholar
  45. 45.
    Lories R, Derese I, Ceuppens J, Luyten F (2003) Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 48: 2807–2818.PubMedCrossRefGoogle Scholar
  46. 46.
    Lundberg C, Asberg I, Ionescu M, Reiner A, Smedegard G, Poole A (1996) Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage. Ann Rheum Dis 55:525–534.PubMedGoogle Scholar
  47. 47.
    Mankin HJ, Dorfman H, Lippiello L, Zarins A (1971) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53A:523–537.Google Scholar
  48. 48.
    Maroudas A, Palla G, Gilav E (1992) Racemization of aspartic acid in human articular cartilage. Connect Tissue Res 28:161–169.PubMedGoogle Scholar
  49. 49.
    Matyas JR, Sandell LJ, Adams ME (1997) Gene expression of type II collagens in chondro-osteophytes in experimental osteoarthritis. Osteoarthritis Cartilage 5:99–105.PubMedCrossRefGoogle Scholar
  50. 50.
    McQuillan DJ, Handley CJ, Campbell MA, Bolis S, Milway VE, Herington AC (1986) Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage. Biochem J 240:423–430.PubMedGoogle Scholar
  51. 51.
    Middleton J, Manthey A, Tyler J (1996) Insulin-like growth factor (IGF) receptor, IGF-I, interleukin-1 beta (IL-1 beta), and IL-6 mRNA expression in osteoarthritic and normal human cartilage. J Histochem Cytochem 44:133–141.PubMedGoogle Scholar
  52. 52.
    Middleton JF, Tyler JA (1992) Upregulation of insulin-like growth factor I gene expression in the lesions of osteoarthritic human articular cartilage. Ann Rheum Dis 51:440–447.PubMedGoogle Scholar
  53. 53.
    Muehleman C, Bareither D, Huch K, Cole A, Kuettner K (1997) Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthritis Cartilage 5:23–37.PubMedCrossRefGoogle Scholar
  54. 54.
    Nakase T, Miyaji T, Tomita T, Kaneko M, Kuriyama K, Myoui A, Sugamoto K, Ochi T, Yoshikawa H (2003) Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. Osteoarthritis Cartilage 11:278–284.PubMedCrossRefGoogle Scholar
  55. 55.
    Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I, Ionescu M, Fraser GL, Brooks E, Tanzer M, Rosenberg LC, Dieppe P, Poole AR (1998) Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 102:2115–2125.PubMedGoogle Scholar
  56. 56.
    Olsen B (1995) Mutations in collagen genes resulting in metaphyseal and epiphyseal. Bone 17:45S–49S.PubMedCrossRefGoogle Scholar
  57. 57.
    Omoto S, Nishida K, Yamaai Y, Shibahara M, Nishida T, Doi T, Asahara H, Nakanishi T, Inoue H, Takigawa M (2004) Expression and localization of connective tissue growth factor (CTGF/Hcs24/CCN2) in osteoarthritic cartilage. Osteoarthritis Cartilage 12:771–778.PubMedCrossRefGoogle Scholar
  58. 58.
    Piek E, Heldin C-H, Ten Dijke P (1999) Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13:2105–2124.PubMedGoogle Scholar
  59. 59.
    Piscoya J, Fermor B, Kraus V, Stabler T, Guilak F (2005) The influence of mechanical compression on the induction of osteoarthritis-related biomarkers in articular cartilage explants. Osteoarthritis Cartilage 13:1092–1099.PubMedCrossRefGoogle Scholar
  60. 60.
    Poole AR, Ionescu M, Swan A, Dieppe PA (1994) Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest 94:25–33.PubMedCrossRefGoogle Scholar
  61. 61.
    Poole CA, Ayad S, Gilbert RT (1992) Chondrons from articular cartilage: V. Immunolocalization of type VI collagen organization in isolated chondrons by light, confocal and electron microscopy. J Cell Sci 103:1101–1110.PubMedGoogle Scholar
  62. 62.
    Pullig O, Weseloh G, Gauer S, Swoboda B (2000) Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol 19: 245–255.PubMedCrossRefGoogle Scholar
  63. 63.
    Pullig O, Weseloh G, Klatt A, Wagener R, Swoboda B (2002) Matrilin-3 in human articular cartilage: increased expression in osteoarthritis. Osteoarthritis Cartilage 10:253–263.PubMedCrossRefGoogle Scholar
  64. 64.
    Pullig O, Weseloh G, Swoboda B (1999) Expression of type VI collagen in normal and osteoarthritic human cartilage. Osteoarthritis Cartilage 7:191–202.PubMedCrossRefGoogle Scholar
  65. 65.
    Rappolee D (1992) Macrophage-derived growth factors. Curr Top Microbiol Immunol 181:87–140.PubMedGoogle Scholar
  66. 66.
    Rizkalla G, Reiner A, Bogoch E, Poole AR (1992) Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 90:2268–2277.PubMedGoogle Scholar
  67. 67.
    Ronziere MC, Ricard-Blum S, Tiollier J, Hartmann DJ, Garrone R, Herbage D (1990) Comparative analysis of collagens solubilized from human foetal, and normal and osteoarthritic adult articular cartilage, with emphasis on type VI collagen. Biochim Biophys Acta 1038:222–230.PubMedGoogle Scholar
  68. 68.
    Rountree R, Schoor M, Chen H, Marks M, Harley V, Mishina Y, Kingsley D (2004) BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol 2:e355.PubMedCrossRefGoogle Scholar
  69. 69.
    Scharstuhl A, Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB (2002) Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 169: 507–514.PubMedGoogle Scholar
  70. 70.
    Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R, Moses HL (1997) Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541–552.PubMedCrossRefGoogle Scholar
  71. 71.
    Squires GR, Okouneff S, Ionescu M, and Poole AR (2003) The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum, May 2003; 48(5):1261–1270.CrossRefGoogle Scholar
  72. 72.
    Tardif G, Hum D, Pelletier J, Boileau C, Ranger P, Martel-Pelletier J (2004) Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 50:2521–2530.PubMedCrossRefGoogle Scholar
  73. 73.
    Tardif G, Pelletier J-P, Hum D, Boileau C, Duval N, Martel-Pelletier J (2006) Differential regulation of the bone morphogenic protein antagonist chordin in human normal and osteoarthritic chondrocytes. Ann Rheum Dis 65:261–264.PubMedCrossRefGoogle Scholar
  74. 74.
    Tesche F, Miosge N (2004) Perlecan in late stages of osteoarthritis of the human knee joint. Osteoarthritis Cartilage 12:852–862.PubMedCrossRefGoogle Scholar
  75. 75.
    Thompson RC, Oegema TR, Jr. (1979) Metabolic activity of articular cartilage in osteoarthritis. An in vitro study. J Bone Joint Surg Am. 61(3):407–416.PubMedGoogle Scholar
  76. 76.
    Van Beuningen H, Glansbeek H, Van der Kraan P, Van den Berg W (2000) Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 8:25–33.PubMedCrossRefGoogle Scholar
  77. 77.
    van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB (1998) Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 6: 306–317.PubMedCrossRefGoogle Scholar
  78. 78.
    Van Lent P, Blom A, Van der Kraan P, Holthuysen A, Vitters E, Van Rooijen N, Smeets R, Nabbe K, Van den Berg W (2004) Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum 50: 103–111.PubMedCrossRefGoogle Scholar
  79. 79.
    van den Berg P, Khillan JS, Prockop DJ, Helminen H, Kontusaari S, Ala-Kokko L (1991) Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. Proc Natl Acad Sci USA 88:7640–7644.CrossRefGoogle Scholar
  80. 80.
    Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, Bijlsma JWJ, Lafeber FPJG, Baynes JW, TeKoppele JM (2000) Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 275:39027–39031.PubMedCrossRefGoogle Scholar
  81. 81.
    Wozney J (2002) Overview of bone morphogenetic proteins. Spine 27:S2–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2007

Authors and Affiliations

  • Naoshi Fukui
  • Linda J. Sandell

There are no affiliations available

Personalised recommendations